Trial Profile
A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Eravacycline (Primary)
- Indications Intra-abdominal infections; Respiratory tract infections; Urinary tract infections
- Focus Pharmacokinetics
- Sponsors Tetraphase Pharmaceuticals
- 08 Oct 2017 Results presented at the IDWeek 2017
- 14 May 2014 New trial record